Search Results

You are looking at 1 - 9 of 9 items for :

  • Framingham risk score x
  • Endocrinology, Diabetology x
Clear All
Open access

Alin Albai, Mirela Frandeș, Ramona Luminița Sandu, Gabriel Spoială, Flavia Hristodorescu, Bogdan Timar and Romulus Timar

, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003, 2003. 6. D’Agostino RB Sr, Vasan RS, Pencina MJ et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-753, 2008. 7. Centers for Disease Control and Prevention . National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for

Open access

Vaia D. Raikou

coronary heart disease is the Framingham risk score (FRS). According to the National Institutes of Health, the patients having chronic kidney disease are considered as having a coronary heart disease risk equivalent, meaning that they are primarily patients with a 10-year risk for myocardial infarction or coronary death >20%, despite without known coronary heart disease. [ 8 ] Metabolic acidosis, a common condition and an important manifestation of the late stage of chronic kidney disease, leads to clinically significant consequences, including bone disease disorders

Open access

Oana Albai and Romulus Timar

European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Risk of Cardiovascular Disease): I. Methodology and objectives. Diabetologia 47: 566-570, 2004. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165: 2644-2650, 2005. DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to

Open access

Volodymyr Pankiv and Ivan Pankiv

body mass index in an urban black community in Mangaung, South Africa. Afr J Prm Health Care Fam Med 8(1): 1210, 2016. 5. Wang S. Epidemiology of vitamin D in health and disease. Nutr Res Rev 22(2): 188-203, 2009 6. Truesdell D, Shin H, Liu PY, Ilich IZ. Vitamin D status and Framingham Risk Score in overweight postmenopausal women. J Womens Health 20(9): 1341- 1348, 2011. 7. Wortsman J, Matsuoka LY, Chen TC et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3): 690-693, 2000. 8

Open access

Cristina Muntean, Adina Mitrea, Maria Mota and Valerica Tudorica

. Johnston S C, Rothwell P M, Nguyen - Huynh M N, Giles M F, Elkins J S, Bernstein A L. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet 369: 283-292, 2007. Holzer K, Feurer R, Sadikovic S, Esposito L, Bockelbrink A, Sander D, Hemmer B, Poppert H. Prognostic value of the ABCD2 score beyond short-term follow-up after transient ischemic attack (TIA) - a cohort study. BMC Neurology 10: 50, 2010. Feldmann E, Broderick J P, Kernan W N, Viscoli CM, Brass L M

Open access

Nikolaos-Dimitrios Pantzaris, Christina Platanaki, Charalampos Pierrako, Vasilios Karamouzos and Dimitrios Velissaris

O, Zararsiz G, Hamit Kücük H, Gürsoy S, et al . Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis. J Clin Lab Anal 2013; 27: 72–6. 10.1002/jcla.21564 Celikbilek M Dogan S Ozbakir O Zararsiz G Hamit Kücük H Gürsoy S Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis J Clin Lab Anal 2013 27 72 6 9 Shah N, Parikh V, Patel N, Patel N, Badheka A, Deshmukh A, et al . Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality

Open access

Mustapha Diaf, Méghit Boumediene Khaled and Feriel Sellam

References 1. Haslam DW, James WP. Obesity. Lancet 366: 1197-209, 2005. 2. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world--a growing challenge. N Engl J Med 356: 213-5, 2007. 3. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117: 743-53, 2008. 4. Grover SA, Kaouache M, Rempel P et al. Years of life lost and healthy life-years lost from diabetes and

Open access

Amir Hodzic, Virginie Ribault, Pascale Maragnes, Paul Milliez, Eric Saloux and Fabien Labombarda

;378:140–6. 10.1016/S0140-6736(11)60471-6 Lind M Bounias I Olsson M Gudbjörnsdottir S Svensson AM Rosengren A Control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study Lancet 2011 378 140 6 4 Kannel WB, Mc Gee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120–6. 10.2337/diacare.2.2.120 Kannel WB Mc Gee DL Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study Diabetes Care 1979 2 120 6 5 Fang ZY, Prins JB

Open access

Zofia Radikova, Adela Penesova, Miroslav Vlcek, Andrea Havranova, Monika Sivakova, Pavel Siarnik, Ingrid Zitnanova, Richard Imrich, Branislav Kollar and Peter Turcani

Framingham risk score of coronary heart disease in middle-aged men with increased non-HDL cholesterol. Int J Cardiol 168, 3853–3858, 2013. Jorissen W, Wouters E, Bogie JF, Vanmierlo T, Noben JP, Sviridov D, Hellings N, Somers V, Valcke R, Vanwijmeersch B, Stinissen P, Mulder MT, Remaley AT, Hendriks JJ. Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL. Sci Rep 7, 43410, 2017. Jorissen W, Vanmierlo T, Wens I, Somers V, Van Wijmeersch B, Bogie JF, Remaley AT, Eijnde BO, Hendriks JJA. Twelve Weeks of